It’s no secret that the only cannabis available for official use on research is provided by the University of Mississippi and NIDA, which is notoriously low in quality. The lawsuit also states that this marijuana is unfit for research because of “poor quality, unstable supply, and limited variability that in no way emulates the types of cannabis currently available through either state-regulated markets or informal markets where regulated supply is unavailable.” What makes it worse is that this cannabis is only allowed for research and not to be sold commercially, which means that it can’t be used for Phase 3 studies of the FDA, required under the Good Manufacturing Processes.
A High Times reader asked why his cones burn evenly and his straight joints canoe.…
Social media platforms have become the new censors of cannabis culture. Josh Kesselman posts at…
Every two years, cannabis advocates wheel out the same ritual. Ballot measures, candidate endorsements, grasstops…
ONDCP director Sara Carter Bailey told Newsmax this week that marijuana is “still illegal” after…
For Mother’s Day, Maya Elisabeth asked mothers across the cannabis community to talk about the…
In 1994, Melanie Dreher published a study showing that cannabis-exposed babies thrived. The medical establishment…